DrugBank Blog

When Your Needs for Clinical Data Grow Beyond OpenFDA and RxNorm

It's easier than you think to migrate from open and free data sources to DrugBank. Discover the best practices and when to make the switch.

Use Cases

Powering RxNorm's Drug Interaction API with DrugBank

Learn how the National Library of Medicine powers the RxNorm's Drug Interaction API with DrugBank's data.

First Look

How to Use US Drug Labels for Clinical Decision Support

Get access to drug manufacturer information with easy-to-integrate US Drug Labels. Enable safe use and prescription of FDA-approved medications.

press releases

DrugBank Expands Coverage to Seven New Regions, Grows Global Influence

We are excited to announce that we have expanded our drug products and indications coverage with seven new regions: Austria, Colombia, Indonesia, Italy, Malaysia, Thailand, and Turkey. This allows DrugBank to better serve global customers and helps existing customers grow into new markets.

Mental Health

Frozen DrugBanker Challenge

We challenged our team to get outside and shake up the work from home routine. This challenge was how we stayed connected while working remotely, took mental health breaks, and explored our cities even when it was too cold.

Announcements

Introducing the Drug Allergy Module

Our new Drug Allergy Module gives you detailed drug allergy and cross-sensitivities information. You can help your clinical users avoid severe drug allergies and manage mild symptoms with ease.

In the News

DrugBank’s Journey to Fueling Global COVID-19 Antiviral Research

It’s been over a year since COVID-19 emerged and DrugBank has been at the forefront of COVID antiviral research. Our two co-founders, Mike Wilson and Craig Knox, sit down (virtually) with Arden Tse from the Accelerate Fund.

A Year in Review: DrugBank’s 2020 Highlights

Happy New Year from our team here at DrugBank! When we authored our year in review at the end of 2019, we couldn’t have predicted what was to come for 2020. It’

COVID19

Research Spotlight: Repositioning of 8,565 existing drugs for COVID-19

Research Spotlight: Learn how a team of researchers used DrugBank to help narrow the search for potential antiviral candidates in COVID-19.

Feature Announcements

DrugBank Winter 2020 Feature Release

DrugBank is excited to share the Winter 2020 Feature Release. Learn about our exciting updates on similar indications lookup, duplicate therapy checker, filtering generics, web token authentication, demo apps repository, and more.

press releases

DrugBank Announces Successful Fundraise, Plans to Scale Rapidly.

October 5, 2020 - FOR IMMEDIATE RELEASE. The DrugBank team is pleased to announce the completion of a successful investment round. Over the past year, DrugBank has focused its efforts to scale its

FDA Approvals Monthly Roundup: August 2020

The FDA is responsible for protecting public health by ensuring the safety, efficacy, and security of human and veterinary drugs. Each month, the administration approves numerous new therapeutics. We have summarized the FDA

FDA Approvals Monthly Roundup: July 2020

The FDA is responsible for protecting public health by ensuring the safety, efficacy, and security of human and veterinary drugs. Each month, the administration approves numerous new therapeutics. We have summarized the FDA

Feature Announcements

Join us on Kaysen's Quest: Learn more about Gene Therapy, Zolgensma

As a company that specializes in drug information, DrugBank always tries to remain informed about novel treatments, drug approvals, and drugs that are impacting global health. At the top of our minds lately

Announcements

FDA Approvals Monthly Roundup: June 2020

The FDA is responsible for protecting public health by ensuring the safety, efficacy, and security of human and veterinary drugs. Each month, the administration approves numerous new therapeutics. We have summarized the FDA

press releases

Edmonton Startup, DrugBank, Graduates from Creative Destruction Lab - West

May 27, 2020 - Edmonton based startup, DrugBank, recently graduated from the 2019/20 Creative Destruction Lab (CDL) Program. CDL is a seed-stage accelerator program for massively scalable, science-based companies. Its nine-month program

COVID19

DrugBank joins as a supporter of Global Virtual Partnering Event to accelerate partnerships in the life sciences industry to fight COVID-19

PRESS CONTACT Shay Barker Operations Manager, DrugBank shay@drugbank.ca FOR IMMEDIATE RELEASE April 20, 2020 - DrugBank is pleased to announce they’ve joined a 3-day global virtual partnering event, organized by

White Paper

UPDATED: COVID-19: Finding the Right Fit

With the global outbreak of COVID-19 spanning news stations and research labs across the world, the DrugBank team put their heads together to provide an overview of current data-driven approaches to identify potential COVID-19 therapies.

press releases

Edmonton Startup, DrugBank, Wins Inaugural Startup TNT $125,000 Investment

PRESS CONTACT Shay Barker Operations Manager, DrugBank shay@drugbank.ca FOR IMMEDIATE RELEASE February 21, 2020 - DrugBank, a local Edmonton technology startup, is the inaugural winner of the Startup TNT Investment Pitch

FDA Approval Roundup - December 2019

Last month the FDA approved ten new drugs aimed at treating a broad spectrum of diseases and ailments. The FDA often approves a number of drugs over a short period of time before

The DrugBank team is headed to the Valley!

With the temperatures dropping substantially here in Alberta, the DrugBank team is excited to be headed to the sunshine in Santa Clara, California from January 21 - 24 for the Precision Medicine World

Announcements

A Year in Review: DrugBank's 2019 Highlights

Happy New Year from our team here at DrugBank! 2019 was a wild year for us, and we wanted to share some of our top highlights with you: 1. We added 8 new

press releases

Edmonton Startup DrugBank Pledges to Offset Company Travel Carbon Emissions

Co-Founders, Michael Wilson and Craig Knox, along with their team, have pledged to mitigate their travel emissions by purchasing carbon offsets for all business-related travel. With the help of Less Emissions, a Bullfrogpower

press releases

Edmonton Startup DrugBank accepted into Creative Destruction Lab - West 2019/20 Cohort

Edmonton based startup, DrugBank, has been accepted into the 2019/20 Creative Destruction Lab (CDL) program year. CDL is a seed-stage program for massively scalable, science-based companies. Its nine-month program pairs founders with

Announcements

DrugBank is Crossing the Pond!

JOIN US AT THE 2019 AI IN DRUG DEVELOPMENT CONGRESS. We are hopping on a red-eye this week headed to London, UK, to take part in the 2019 AI in Drug Development Congress.